These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8139147)

  • 1. [Urinary cross-linked FDP in various renal diseases].
    Inuma H
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K; Matsunaga T; Kawahara S; Sakamoto S; Kamitsuji H
    Thromb Res; 1989 Feb; 53(4):367-77. PubMed ID: 2929008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary cross-linked fibrin degradation products in glomerular disease with crescents.
    Kamitsuji H; Matsunaga K; Taira K; Nakajima M; Whitworth JA; Kincaid-Smith P
    Clin Nephrol; 1988 Mar; 29(3):124-8. PubMed ID: 3359703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
    Shibata T; Magari Y; Mizunaga S; Okabe E; Sumie A; Ishii T; Tomo T; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
    Kaizu K; Ito Y; Uriu K; Komine N; Hashimoto O; Eto S
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary crosslinked fibrin degradation products in glomerular disease.
    Kamitsuji H; Whitworth JA; Dowling JP; Kincaid-Smith P
    Am J Kidney Dis; 1986 Jun; 7(6):452-5. PubMed ID: 3717150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
    Shibata T; Magari Y; Perparim K; Sumie A; Ishii T; Tomo T; Sato J; Yasumori R; Nasu M
    Nephron; 1995; 69(1):54-8. PubMed ID: 7891798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K; Dohi K; Fujii Y; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin of urinary fibrin-fibrinogen degradation products in renal glomerular disease.
    Hall CL; Blainey JD; Gaffney PJ
    Nephron; 1979; 23(1):6-9. PubMed ID: 450168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
    Michielsen P; Roels L; Vanrenterghem Y; Boel A; van Damme B; Vermylen J
    Clin Nephrol; 1976 Mar; 5(3):105-13. PubMed ID: 1261101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrin degradation products in the urine in diabetic nephropathy].
    Khristov V; Apostolov P; Stamenova T
    Vutr Boles; 1979; 18(4):32-6. PubMed ID: 494630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary fibrinogen and fibrin fragments in children with renal disease.
    Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S
    Nephron; 1982; 32(2):135-9. PubMed ID: 7177290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
    Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
    Astrug A; Shipkova P
    Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis.
    Sakakibara K; Nagase M; Takada Y; Takada A
    Thromb Res; 1987 Feb; 45(4):403-11. PubMed ID: 3576523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.